Fungal infections represent a growing concern in both immunocompromised and immunocompetent individuals. Conventional identification methods, including culture, microscopy, and biochemical testing, often require several days and may lack sensitivity or specificity for certain opportunistic fungi. Molecular techniques such as PCR and sequencing have improved accuracy but remain costly and time-consuming in routine practice. Recently, Artificial Intelligence (AI), encompassing machine learning (ML) and deep learning (DL) approaches, has emerged as a revolutionary tool to accelerate fungal identification. AI-powered platforms can analyze complex image datasets, molecular fingerprints, or mass spectrometry outputs, thereby enhancing the speed, precision, and reproducibility of fungal diagnostics.
Fig. Yeast cells and hyphae in a wet mount of culture microscopy at a magnification of 1600X
Image-Based AI Models
Microscopy & Histopathology: Convolutional neural networks (CNNs) can detect fungal hyphae, yeast cells, or spores in digitized slides of histopathological or direct microscopic specimens.
Culture Plate Recognition: AI models trained on thousands of colony images can differentiate Candida, Aspergillus, and dermatophytes by colony texture, pigmentation, and growth patterns.
Spectral and Molecular Data Interpretation
MALDI-TOF MS Data: AI algorithms enhance peak recognition and database matching, reducing misidentification of cryptic species such as Candida auris.
Genomics and Metagenomics: Machine learning pipelines enable the classification of fungal DNA/RNA sequencing data with greater speed, facilitating pathogen prediction in metagenomic next-generation sequencing (mNGS) datasets.
Predictive Modeling
AI integrates patient metadata, antifungal susceptibility profiles, and genomic markers to predict drug resistance (e.g., azole resistance in Aspergillus fumigatus).
Risk-scoring models help clinicians detect invasive fungal infections (IFIs) early, before culture confirmation.
Clinical Significance
Fig. Hyphae and conidia of Curvularia in LPCB tease mount of culture microscopy at a magnification of 1600X
Rapid Diagnosis: AI shortens turnaround time, which is critical in high-mortality infections like cryptococcosis or mucormycosis.
Enhanced Accuracy: Reduces human error in microscopy interpretation and overcomes morphological overlap between species.
Resource Optimization: Provides diagnostic support in regions lacking mycology experts, bridging healthcare gaps.
Personalized Medicine: AI helps predict patient-specific outcomes, guiding prophylaxis and therapeutic decisions in oncology and transplant units.
Keynotes
AI significantly improves the sensitivity and specificity of fungal identification compared to conventional methods.
Image-based deep learning models can detect fungi in clinical and environmental samples with near-expert accuracy.
AI integration with MALDI-TOF MS and sequencing data enhances the detection of cryptic and rare fungi.
Clinical deployment is still limited by dataset availability, algorithm transparency, and regulatory approvals.
Future directions include real-time AI-assisted point-of-care devices, cloud-based diagnostic platforms, and integration with hospital electronic health records
